Original language | English |
---|---|
Pages (from-to) | 626-629 |
Number of pages | 4 |
Journal | Nature Medicine |
Volume | 28 |
Issue number | 4 |
DOIs |
|
State | Published - Apr 2022 |
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
Thomas U. Marron, Matthew D. Galsky, Bachir Taouli, Maria Isabel Fiel, Stephen Ward, Edward Kim, David Yankelevitz, Deborah Doroshow, Emma Guttman, Benjamin Ungar, Saurabh Mehandru, Benjamin J. Golas, Daniel Labow, John Sfakianos, Sujit S. Nair, Dimple Chakravarty, Michael Buckstein, Xiaoyu Song, Effi Kenigsberg, Sacha Gnjatic
- Cancer Clinical Investigation
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Medicine
- Medicine - Hematology and Medical Oncology
- The Tisch Cancer Institute
- Urology
- BioMedical Engineering and Imaging Institute
- Cancer/Body
- Friedman Brain Institute
- Liver Cancer
- Radiology (Diagnostic, Molecular and Interventional Radiology)
- Pathology, Molecular and Cell-Based Medicine
- Waldman Department of Dermatology
- Medicine - Gastroenterology
- Surgery
- Radiation Oncology
- Cancer Immunology
- Human Immune Monitoring Center
- Oncological Sciences
- Center for Inborn Errors of Immunity
- Genetics and Genomic Sciences
- Icahn Genomics Institute
- Mindich Child Health and Development Institute
- Recanati Miller Transplantation Institute
Research output: Contribution to journal › Comment/debate
1
Scopus
citations